Citation Impact
Citing Papers
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
2008
Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis
2018
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by Vα14 i NKT Cells
2009
Tolerization of Tumor-Specific T Cells Despite Efficient Initial Priming in a Primary Murine Model of Prostate Cancer
2007
Intestinal Monocyte-Derived Macrophages Control Commensal-Specific Th17 Responses
2015
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
Therapeutic cancer vaccines: are we there yet?
2010
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
2018
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Modular and tunable biological feedback control using a de novo protein switch
2019 StandoutNatureNobel
Combining immunotherapy and targeted therapies in cancer treatment
2012
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
T-cell-receptor gene therapy
2002
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
The Principles of Engineering Immune Cells to Treat Cancer
2017
SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells
2005 Nature
CD1-Restricted T Cells and Tumor Immunity
2007
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
2005 Nature
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
2006
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Immune surveillance of tumors
2007
Metazoan MicroRNAs
2018 Standout
Chromatin states define tumour-specific T cell dysfunction and reprogramming
2017 Nature
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2018
Localization, Quantitation, and In Situ Detection of Specific Peptide–MHC Class I Complexes Using a Monoclonal Antibody
1997
Mechanisms of Exogenous Antigen Presentation by MHC Class I Molecules in Vitro and in Vivo: Implications for Generating CD8+ T Cell Responses to Infectious Agents, Tumors, Transplants, and Vaccines
1999
Immunity, Inflammation, and Cancer
2010 Standout
Natural killer cells act as rheostats modulating antiviral T cells
2011 Nature
Emerging Biological Principles of Metastasis
2017 Standout
Antigens for cancer immunotherapy
2008
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis
2008
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells
2010
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9
2006 StandoutNobel
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Going both ways: Immune regulation via CD1d-dependent NKT cells
2004
Molecular and cellular insights into T cell exhaustion
2015 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Do autochthonous tumors interfere with effector T cell responses?
2007
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Confronting Complexity: Real-World Immunodominance in Antiviral CD8+ T Cell Responses
2006
Immune control of herpes simplex virus during latency
2004
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells
1998 StandoutNobel
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
2006 StandoutNobel
CD8α+ and CD11b+ Dendritic Cell-Restricted MHC Class II Controls Th1 CD4+ T Cell Immunity
2003
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen
2005
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Therapeutic Targeting of the Tumor Microenvironment
2021
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
1999
Going both ways: Immune regulation via CD1d-dependent NKT cells
2004
Chimeric Antigen Receptor Therapy
2018 Standout
Does the Immune System See Tumors as Foreign or Self?
2003
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes
2005
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
1997 StandoutNobel
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer
2018
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways
1999 StandoutNobel
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
2006 StandoutNobel
De novo design of protein logic gates
2020 StandoutScienceNobel
Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand From a Greatly Reduced Precursor Pool
2001
Works of Todd D. Schell being referenced
T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients
2016
TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation
2008
Presentation of a horse cytochrome c peptide by multiple H‐2b class I major histocompatibility complex (MHC) molecules to C57BL/6‐ and bm1‐derived cytotoxic T lymphocytes: Presence of a single MHC anchor residue may confer efficient peptide‐specific CTL recognition
1994
Regression of Established Hepatocellular Carcinoma Is Induced by Chemoimmunotherapy in An Orthotopic Murine Model
2011
The dual role of CD8+ T lymphocytes in the development of stress-induced herpes simplex encephalitis
2003
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
2016
Purification of dendritic cell and macrophage subsets from the normal mouse small intestine
2015
Accumulation of CD8+ T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope
2006
Inefficient Cross-Presentation Limits the CD8+ T Cell Response to a Subdominant Tumor Antigen Epitope
2005
Cytotoxic T-Lymphocyte Epitope Immunodominance in the Control of Choroid Plexus Tumors in Simian Virus 40 Large T Antigen Transgenic Mice
1999
Another View of T Cell Antigen Recognition: Cooperative Engagement of Glycolipid Antigens by Va14Ja18 Natural TCR
2003
An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope
1998
Quantitation of CD8+T-Lymphocyte Responses to Multiple Epitopes from Simian Virus 40 (SV40) Large T Antigen in C57BL/6 Mice Immunized with SV40, SV40 T-Antigen-Transformed Cells, or Vaccinia Virus Recombinants Expressing Full-Length T Antigen or Epitope Minigenes
2000
Early Immunization Induces Persistent Tumor-Infiltrating CD8+ T Cells against an Immunodominant Epitope and Promotes Lifelong Control of Pancreatic Tumor Progression in SV40 Tumor Antigen Transgenic Mice
2006
Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.
2000
CD8 T Cells Recruited Early in Mouse Polyomavirus Infection Undergo Exhaustion
2012
In Vivo Ligation of CD40 Enhances Priming Against the Endogenous Tumor Antigen and Promotes CD8+ T Cell Effector Function in SV40 T Antigen Transgenic Mice
2003